RxSight (RXST) Amortization of Deferred Charges (2020 - 2025)
RxSight's (RXST) quarterly Amortization of Deferred Charges came in at -$9000.0 in Q2 2025, down 212.5% YoY from $8000.0 in Q2 2024, and down 200.0% on a QoQ basis from $9000.0 in Q1 2025.
RxSight (RXST) Amortization of Deferred Charges (2020 - 2025) Analysis & Trends
RxSight (RXST) has 6 years of Amortization of Deferred Charges data on file, last reported at -$9000.0 in Q2 2025.
- Quarterly Amortization of Deferred Charges fell 212.5% year-over-year to -$9000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$9000.0 (up 43.75% YoY) and the FY2023 annual result came in at $287000.0, down 48.01% from the prior year.
- Amortization of Deferred Charges retreated to -$9000.0 in Q2 2025, from $9000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $457000.0 in Q4 2022 to a low of -$99000.0 in Q2 2021.
- A 5-year average of $47333.3 and a median of $17000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 7716.67% — and 2025, when it slumped 212.5%.
- Tracing RXST's Amortization of Deferred Charges over 5 years: stood at -$6000.0 in 2021, then jumped by 7716.67% to $457000.0 in 2022, then plunged by 66.08% to $155000.0 in 2023, then tumbled by 126.45% to -$41000.0 in 2024, then soared by 78.05% to -$9000.0 in 2025.
- The last three Amortization of Deferred Charges figures came in at -$9000.0 (Q2 2025), $9000.0 (Q1 2025), and -$41000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 44,000.00 |
| Mar 31, 2023 | 44,000.00 |